Literature DB >> 23525500

Activated peroxisomal fatty acid metabolism improves cardiac recovery in ischemia-reperfusion.

Edgars Liepinsh1, Elina Skapare, Janis Kuka, Marina Makrecka, Helena Cirule, Edijs Vavers, Eduards Sevostjanovs, Solveiga Grinberga, Osvalds Pugovics, Maija Dambrova.   

Abstract

Depressed oxidation of long chain fatty acids (LCFA) in heart ischemia leads to acute accumulation of LCFA metabolites that impair the functioning of the mitochondria. We hypothesized that reduced activity of carnitine palmitoyltransferase-I (CPT-I) might activate peroxisomal LCFA oxidation and protect mitochondrial function in ischemia and reperfusion. In the present study, despite the long-term threefold reduction in L-carnitine content by 3-(2,2,2-trimethylhydrazinium)-propionate, the uptake and oxidation rates of LCFA in the heart in normoxia were not significantly influenced. The significant increase in PPARα and PGC1α nuclear content, observed in this study, were followed by increased expression of genes involved in peroxisomal fatty acid oxidation (FAO) which compensated for the limited CPT-I-dependent FA transport into the mitochondria. In ischemia followed by reperfusion, the redirection of LCFA oxidation from mitochondria to peroxisomes protected the mitochondria from the accumulation of LCFA. In turn, the recovery of FAO resulted in significant reduction of myocardial infarct size. In conclusion, the decreased L-carnitine content in the heart preserves its peroxisomal and mitochondrial function after ischemia and improves cardiac recovery during reperfusion. The functional interplay between the decrease in L-carnitine and the PPARα/PGC1α pathway-induced redirection of FA metabolism protects the mitochondria against LCFA overload and provides a foundation for novel cardioprotective mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525500     DOI: 10.1007/s00210-013-0849-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

Review 1.  Peroxisomal beta-oxidation--a metabolic pathway with multiple functions.

Authors:  Yves Poirier; Vasily D Antonenkov; Tuomo Glumoff; J Kalervo Hiltunen
Journal:  Biochim Biophys Acta       Date:  2006-08-30

2.  Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.

Authors:  Edgars Liepinsh; Reinis Vilskersts; Dagnija Loca; Olga Kirjanova; Osvalds Pugovichs; Ivars Kalvinsh; Maija Dambrova
Journal:  J Cardiovasc Pharmacol       Date:  2006-12       Impact factor: 3.105

3.  Cardioprotective profile of MET-88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts.

Authors:  N Asaka; Y Muranaka; T Kirimoto; H Miyake
Journal:  Fundam Clin Pharmacol       Date:  1998       Impact factor: 2.748

4.  A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis.

Authors:  G C Sparagna; D L Hickson-Bick; L M Buja; J B McMillin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

5.  The cardioprotective effect of mildronate is diminished after co-treatment with L-carnitine.

Authors:  Janis Kuka; Reinis Vilskersts; Helena Cirule; Marina Makrecka; Osvalds Pugovics; Ivars Kalvinsh; Maija Dambrova; Edgars Liepinsh
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011-09-08       Impact factor: 2.457

Review 6.  Targeting AMPK for cardiac protection: opportunities and challenges.

Authors:  Maengjo Kim; Rong Tian
Journal:  J Mol Cell Cardiol       Date:  2010-12-13       Impact factor: 5.000

7.  Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.

Authors:  Edgars Liepinsh; Reinis Vilskersts; Liga Zvejniece; Baiba Svalbe; Elina Skapare; Janis Kuka; Helena Cirule; Solveiga Grinberga; Ivars Kalvinsh; Maija Dambrova
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

8.  Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.

Authors:  Sudhiranjan Gupta; David Young; Ratan K Maitra; Anasuya Gupta; Zoran B Popovic; Sandro L Yong; Anjuli Mahajan; Qing Wang; Subha Sen
Journal:  J Mol Biol       Date:  2007-10-10       Impact factor: 5.469

9.  Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.

Authors:  Joost J F P Luiken; Hanneke E C Niessen; Susan L M Coort; Nicole Hoebers; Will A Coumans; Robert W Schwenk; Arend Bonen; Jan F C Glatz
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

10.  PPAR{alpha} attenuates the proinflammatory response in activated mesangial cells.

Authors:  Keiichi Kono; Yuji Kamijo; Kazuhiko Hora; Kyoko Takahashi; Makoto Higuchi; Kendo Kiyosawa; Hidekazu Shigematsu; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-26
View more
  9 in total

1.  Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction.

Authors:  E Liepinsh; M Makrecka-Kuka; J Kuka; R Vilskersts; E Makarova; H Cirule; E Loza; D Lola; S Grinberga; O Pugovics; I Kalvins; M Dambrova
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Meldonium Ameliorates Hypoxia-Induced Lung Injury and Oxidative Stress by Regulating Platelet-Type Phosphofructokinase-Mediated Glycolysis.

Authors:  Daohui Wang; Fengying Liu; Weijie Yang; Yangyang Sun; Xiaoning Wang; Xin Sui; Jun Yang; Qian Wang; Wenhao Song; Minmin Zhang; Zhenyu Xiao; Tian Wang; Yongan Wang; Yuan Luo
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

3.  Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria.

Authors:  Marina Makrecka; Janis Kuka; Kristine Volska; Unigunde Antone; Eduards Sevostjanovs; Helena Cirule; Solveiga Grinberga; Osvalds Pugovics; Maija Dambrova; Edgars Liepinsh
Journal:  Mol Cell Biochem       Date:  2014-05-31       Impact factor: 3.396

Review 4.  The Peroxisome-Mitochondria Connection: How and Why?

Authors:  Marc Fransen; Celien Lismont; Paul Walton
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

5.  Dietary rescue of lipotoxicity-induced mitochondrial damage in Peroxin19 mutants.

Authors:  Julia Sellin; Christian Wingen; Dominic Gosejacob; Deniz Senyilmaz; Lea Hänschke; Sven Büttner; Katharina Meyer; Daniele Bano; Pierluigi Nicotera; Aurelio A Teleman; Margret H Bülow
Journal:  PLoS Biol       Date:  2018-06-19       Impact factor: 8.029

6.  Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights.

Authors:  Joséphine Gander; Justin Carrard; Hector Gallart-Ayala; Rébecca Borreggine; Tony Teav; Denis Infanger; Flora Colledge; Lukas Streese; Jonathan Wagner; Christopher Klenk; Gilles Nève; Raphael Knaier; Henner Hanssen; Arno Schmidt-Trucksäss; Julijana Ivanisevic
Journal:  Front Cardiovasc Med       Date:  2021-12-16

7.  Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19.

Authors:  Reinis Vilskersts; Dana Kigitovica; Stanislava Korzh; Melita Videja; Karlis Vilks; Helena Cirule; Andris Skride; Marina Makrecka-Kuka; Edgars Liepinsh; Maija Dambrova
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

8.  Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion via stimulation of fatty acid oxidation-linked respiration and PGC-1α/NRF-1 signaling.

Authors:  Ioanna Papatheodorou; Marina Makrecka-Kuka; Janis Kuka; Edgars Liepinsh; Maija Dambrova; Antigone Lazou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-15       Impact factor: 6.055

9.  Landscape of heart proteome changes in a diet-induced obesity model.

Authors:  Danielle F Vileigas; Victoria M Harman; Paula P Freire; Cecília L C Marciano; Paula G Sant'Ana; Sérgio L B de Souza; Gustavo A F Mota; Vitor L da Silva; Dijon H S Campos; Carlos R Padovani; Katashi Okoshi; Robert J Beynon; Lucilene D Santos; Antonio C Cicogna
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.